Tryptophan–kynurenine ratio as a biomarker of bladder cancer

Objectives To investigate plasma and urinary kynurenine (KYN)–tryptophan (TRP) ratios in bladder cancer, expression of indoleamine 2,3‐dioxygenase 1 (IDO1) in relation to tryptophan 2,3‐dioxygenase (TDO2) in bladder tumour, and the correlation of KYN–TRP ratio with bladder tumour burden. Methods Met...

Full description

Saved in:
Bibliographic Details
Published inBJU international Vol. 127; no. 4; pp. 445 - 453
Main Authors Lee, Sze Han, Mahendran, Ratha, Tham, Sin Mun, Thamboo, Thomas Paulraj, Chionh, Billy Jianhao, Lim, Yi Xin, Tsang, Woon Chau, Wu, Qing Hui, Chia, Jun Yang, Tay, Melissa Hui Wen, Goh, Benjamin Yen Seow, Chen, Kelven Weijing, Mallari, Jeane Zepeda, Periaswami, Revathi, Raman, Lata, Choo, Shoa Nian, Kioh, Dorinda Yan Qin, Chiong, Edmund, Esuvaranathan, Kesavan, Chan, Eric Chun Yong
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objectives To investigate plasma and urinary kynurenine (KYN)–tryptophan (TRP) ratios in bladder cancer, expression of indoleamine 2,3‐dioxygenase 1 (IDO1) in relation to tryptophan 2,3‐dioxygenase (TDO2) in bladder tumour, and the correlation of KYN–TRP ratio with bladder tumour burden. Methods Metabotyping of the TRP–KYN metabolic axis was performed via a clinical case–control study. Expression of IDO1 and TDO2 was measured in human biopsied tissues. Correlational experiments between KYN–TRP ratio and bladder tumour were performed using a murine orthotopic prostate‐specific antigen (PSA)‐secreting MB49 bladder cancer model. Results We established for the first time that plasma TRP level was significantly decreased, while both plasma and urinary KYN–TRP ratios were significantly higher in bladder cancer patients, and expression level of IDO1 but not TDO2 was increased in human bladder tumour. We reported the positive correlation between IDO1 expression, KYN–TRP ratio, normalized PSA to creatinine, and bladder tumour burden in the murine model. Conclusion Kynurenine–tryptophan ratio is a promising surveillance biomarker for bladder cancer, but would require further validation before clinical translation.
AbstractList OBJECTIVESTo investigate plasma and urinary kynurenine (KYN)-tryptophan (TRP) ratios in bladder cancer, expression of indoleamine 2,3-dioxygenase 1 (IDO1) in relation to tryptophan 2,3-dioxygenase (TDO2) in bladder tumour, and the correlation of KYN-TRP ratio with bladder tumour burden. METHODSMetabotyping of the TRP-KYN metabolic axis was performed via a clinical case-control study. Expression of IDO1 and TDO2 was measured in human biopsied tissues. Correlational experiments between KYN-TRP ratio and bladder tumour were performed using a murine orthotopic prostate-specific antigen (PSA)-secreting MB49 bladder cancer model. RESULTSWe established for the first time that plasma TRP level was significantly decreased, while both plasma and urinary KYN-TRP ratios were significantly higher in bladder cancer patients, and expression level of IDO1 but not TDO2 was increased in human bladder tumour. We reported the positive correlation between IDO1 expression, KYN-TRP ratio, normalized PSA to creatinine, and bladder tumour burden in the murine model. CONCLUSIONKynurenine-tryptophan ratio is a promising surveillance biomarker for bladder cancer, but would require further validation before clinical translation.
Objectives To investigate plasma and urinary kynurenine (KYN)–tryptophan (TRP) ratios in bladder cancer, expression of indoleamine 2,3‐dioxygenase 1 (IDO1) in relation to tryptophan 2,3‐dioxygenase (TDO2) in bladder tumour, and the correlation of KYN–TRP ratio with bladder tumour burden. Methods Metabotyping of the TRP–KYN metabolic axis was performed via a clinical case–control study. Expression of IDO1 and TDO2 was measured in human biopsied tissues. Correlational experiments between KYN–TRP ratio and bladder tumour were performed using a murine orthotopic prostate‐specific antigen (PSA)‐secreting MB49 bladder cancer model. Results We established for the first time that plasma TRP level was significantly decreased, while both plasma and urinary KYN–TRP ratios were significantly higher in bladder cancer patients, and expression level of IDO1 but not TDO2 was increased in human bladder tumour. We reported the positive correlation between IDO1 expression, KYN–TRP ratio, normalized PSA to creatinine, and bladder tumour burden in the murine model. Conclusion Kynurenine–tryptophan ratio is a promising surveillance biomarker for bladder cancer, but would require further validation before clinical translation.
To investigate plasma and urinary kynurenine (KYN)-tryptophan (TRP) ratios in bladder cancer, expression of indoleamine 2,3-dioxygenase 1 (IDO1) in relation to tryptophan 2,3-dioxygenase (TDO2) in bladder tumour, and the correlation of KYN-TRP ratio with bladder tumour burden. Metabotyping of the TRP-KYN metabolic axis was performed via a clinical case-control study. Expression of IDO1 and TDO2 was measured in human biopsied tissues. Correlational experiments between KYN-TRP ratio and bladder tumour were performed using a murine orthotopic prostate-specific antigen (PSA)-secreting MB49 bladder cancer model. We established for the first time that plasma TRP level was significantly decreased, while both plasma and urinary KYN-TRP ratios were significantly higher in bladder cancer patients, and expression level of IDO1 but not TDO2 was increased in human bladder tumour. We reported the positive correlation between IDO1 expression, KYN-TRP ratio, normalized PSA to creatinine, and bladder tumour burden in the murine model. Kynurenine-tryptophan ratio is a promising surveillance biomarker for bladder cancer, but would require further validation before clinical translation.
Author Tham, Sin Mun
Chia, Jun Yang
Goh, Benjamin Yen Seow
Chiong, Edmund
Lim, Yi Xin
Mahendran, Ratha
Esuvaranathan, Kesavan
Mallari, Jeane Zepeda
Choo, Shoa Nian
Chan, Eric Chun Yong
Wu, Qing Hui
Periaswami, Revathi
Tay, Melissa Hui Wen
Chionh, Billy Jianhao
Raman, Lata
Kioh, Dorinda Yan Qin
Tsang, Woon Chau
Lee, Sze Han
Thamboo, Thomas Paulraj
Chen, Kelven Weijing
Author_xml – sequence: 1
  givenname: Sze Han
  surname: Lee
  fullname: Lee, Sze Han
  organization: National University of Singapore
– sequence: 2
  givenname: Ratha
  surname: Mahendran
  fullname: Mahendran, Ratha
  organization: National University of Singapore
– sequence: 3
  givenname: Sin Mun
  surname: Tham
  fullname: Tham, Sin Mun
  organization: National University of Singapore
– sequence: 4
  givenname: Thomas Paulraj
  surname: Thamboo
  fullname: Thamboo, Thomas Paulraj
  organization: National University Health System
– sequence: 5
  givenname: Billy Jianhao
  surname: Chionh
  fullname: Chionh, Billy Jianhao
  organization: National University of Singapore
– sequence: 6
  givenname: Yi Xin
  surname: Lim
  fullname: Lim, Yi Xin
  organization: National University of Singapore
– sequence: 7
  givenname: Woon Chau
  surname: Tsang
  fullname: Tsang, Woon Chau
  organization: National University Health System
– sequence: 8
  givenname: Qing Hui
  surname: Wu
  fullname: Wu, Qing Hui
  organization: National University Health System
– sequence: 9
  givenname: Jun Yang
  surname: Chia
  fullname: Chia, Jun Yang
  organization: National University Health System
– sequence: 10
  givenname: Melissa Hui Wen
  surname: Tay
  fullname: Tay, Melissa Hui Wen
  organization: National University Health System
– sequence: 11
  givenname: Benjamin Yen Seow
  surname: Goh
  fullname: Goh, Benjamin Yen Seow
  organization: National University Health System
– sequence: 12
  givenname: Kelven Weijing
  surname: Chen
  fullname: Chen, Kelven Weijing
  organization: National University Health System
– sequence: 13
  givenname: Jeane Zepeda
  surname: Mallari
  fullname: Mallari, Jeane Zepeda
  organization: National University Health System
– sequence: 14
  givenname: Revathi
  surname: Periaswami
  fullname: Periaswami, Revathi
  organization: National University of Singapore
– sequence: 15
  givenname: Lata
  surname: Raman
  fullname: Raman, Lata
  organization: National University of Singapore
– sequence: 16
  givenname: Shoa Nian
  surname: Choo
  fullname: Choo, Shoa Nian
  organization: National University Health System
– sequence: 17
  givenname: Dorinda Yan Qin
  surname: Kioh
  fullname: Kioh, Dorinda Yan Qin
  organization: National University of Singapore
– sequence: 18
  givenname: Edmund
  surname: Chiong
  fullname: Chiong, Edmund
  organization: National University Health System
– sequence: 19
  givenname: Kesavan
  surname: Esuvaranathan
  fullname: Esuvaranathan, Kesavan
  organization: National University Health System
– sequence: 20
  givenname: Eric Chun Yong
  orcidid: 0000-0001-6107-9072
  surname: Chan
  fullname: Chan, Eric Chun Yong
  email: phaccye@nus.edu.sg
  organization: National University of Singapore
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32794357$$D View this record in MEDLINE/PubMed
BookMark eNp1kMlKA0EQhhuJmEUPvoAMeNFDtNdZLoIGVwJeEvDWdM9U48RJd-zOILn5Dr6hT2JrEg-Cdami-Pio-vuoY50FhA4JPiOxzvWsPSOCYrGDeoSnfMgJfupsZ1ykXdQPYYZxXKRiD3UZzQrORNZDFxO_Wizd4lnZz_ePl5VtPdjaQuLVsnaJColKdO3myr-AT5xJdKOqKo6lsiX4fbRrVBPgYNMHaHpzPRndDcePt_ejy_GwZIKJYa40zwzHORWgMGFaUEoMhawyYIQhtCpSkWrBeKkELUpFBU9VAZprQ8BQNkAna-_Cu9cWwlLO61BC0ygLrg2ScsZ5TnJOInr8B5251tt4naSCEJwXOcsidbqmSu9C8GDkwtfxy5UkWH6HKmOo8ifUyB5tjK2eQ_VLblOMwPkaeKsbWP1vklcP07XyC7l5gio
CitedBy_id crossref_primary_10_2147_IJN_S354590
crossref_primary_10_3748_wjg_v26_i45_7173
crossref_primary_10_3389_fimmu_2023_1283792
crossref_primary_10_1016_j_bcp_2024_116172
crossref_primary_10_1039_D4AN00418C
crossref_primary_10_2174_1871530322666220104103905
crossref_primary_10_1007_s00726_021_03113_5
crossref_primary_10_3389_fonc_2023_1116016
crossref_primary_10_1038_s41598_023_36874_y
crossref_primary_10_3389_fonc_2024_1331215
crossref_primary_10_3390_ijms22094403
crossref_primary_10_1016_j_canlet_2023_216076
crossref_primary_10_1186_s12885_021_08855_9
crossref_primary_10_1186_s40170_023_00324_0
crossref_primary_10_3390_metabo12020154
crossref_primary_10_1016_j_ajur_2022_11_005
crossref_primary_10_3389_fonc_2022_852718
crossref_primary_10_20517_mrr_2023_47
Cites_doi 10.1158/0008-5472.CAN-17-2285
10.1007/s40273-014-0194-2
10.1200/JCO.2019.37.7_suppl.358
10.1200/JCO.2019.37.7_suppl.TPS493
10.1111/j.1464-410X.2008.08323.x
10.7326/M15-0997
10.1038/nature10491
10.1111/bju.13760
10.1016/j.jchromb.2017.04.010
10.1158/1078-0432.CCR-18-2882
10.1016/j.tranon.2018.11.012
10.3322/caac.20073
10.1158/1078-0432.CCR-04-0605
10.1111/j.1464-410X.2008.07966.x
10.1016/S0140-6736(16)30512-8
10.1126/science.1260419
10.1016/j.eururo.2009.06.028
10.1200/JCO.2001.19.3.666
10.1073/pnas.1113873109
10.1016/j.juro.2016.06.049
10.1016/j.eururo.2012.09.057
10.1021/pr901173v
10.1016/j.clinbiochem.2018.04.014
10.4137/IJTR.S38189
10.4049/jimmunol.1000815
10.1177/1178646917694600
10.1089/met.2017.0097
ContentType Journal Article
Copyright 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd
2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.
BJUI © 2021 BJU International
Copyright_xml – notice: 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd
– notice: 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.
– notice: BJUI © 2021 BJU International
DBID NPM
AAYXX
CITATION
7QP
7X8
DOI 10.1111/bju.15205
DatabaseName PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Calcium & Calcified Tissue Abstracts

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1464-410X
EndPage 453
ExternalDocumentID 10_1111_bju_15205
32794357
BJU15205
Genre article
Journal Article
GrantInformation_xml – fundername: National University Health System (NUHS) Innovation Grant
  funderid: NUHSRO/2018/041/Innov/03
– fundername: NUHS Global Collaboration Centre Grant
  funderid: NUHSRO/2015/065/GCC/02
– fundername: National University Health System (NUHS) Innovation Grant
  grantid: NUHSRO/2018/041/Innov/03
– fundername: NUHS Global Collaboration Centre Grant
  grantid: NUHSRO/2015/065/GCC/02
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
~IA
~WT
NPM
AAMNL
AAYXX
CITATION
7QP
7X8
ID FETCH-LOGICAL-c3535-8ab47f40825ea013b5221f2e7dfef5f12d9656b534ca529ca2546a9eb4bf1ef23
IEDL.DBID DR2
ISSN 1464-4096
IngestDate Wed Dec 04 06:22:30 EST 2024
Tue Nov 19 04:44:16 EST 2024
Fri Dec 06 01:05:45 EST 2024
Sat Sep 28 08:23:23 EDT 2024
Sat Aug 24 01:02:22 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords uroonc
blcsm
bladder cancer
kynurenine
utuc
surveillance
BladderCancer
biomarker
tryptophan
Language English
License 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3535-8ab47f40825ea013b5221f2e7dfef5f12d9656b534ca529ca2546a9eb4bf1ef23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6107-9072
PMID 32794357
PQID 2511089837
PQPubID 1026371
PageCount 9
ParticipantIDs proquest_miscellaneous_2434481841
proquest_journals_2511089837
crossref_primary_10_1111_bju_15205
pubmed_primary_32794357
wiley_primary_10_1111_bju_15205_BJU15205
PublicationCentury 2000
PublicationDate April 2021
2021-Apr
2021-04-00
20210401
PublicationDateYYYYMMDD 2021-04-01
PublicationDate_xml – month: 04
  year: 2021
  text: April 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Edgecliff
PublicationTitle BJU international
PublicationTitleAlternate BJU Int
PublicationYear 2021
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2017; 119
2015; 163
2011; 478
1973; 33
2015; 347
2019; 12
2019; 37
2013; 63
2016; 388
2008; 102
2015; 8
2012; 109
2010; 60
2009; 56
2004; 10
2017; 1054
2017; 77
2017; 10
2019; 25
2001; 19
2015; 2017
2018; 56
2018; 16
2016; 196
2009; 104
2016; 9
2014; 32
2010; 9
2011; 187
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
Gailani S (e_1_2_7_15_1) 1973; 33
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
(NICE) NI of H and CE (e_1_2_7_12_1) 2015; 2017
e_1_2_7_29_1
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
Yang C (e_1_2_7_18_1) 2015; 8
e_1_2_7_24_1
e_1_2_7_23_1
e_1_2_7_22_1
e_1_2_7_21_1
e_1_2_7_20_1
References_xml – volume: 8
  start-page: 1768
  year: 2015
  end-page: 75
  article-title: Expression and function analysis of indoleamine 2 and 3‐dioxygenase in bladder urothelial carcinoma
  publication-title: Int J Clin Exp Pathol
– volume: 16
  start-page: 135
  year: 2018
  end-page: 42
  article-title: Dysregulation of tryptophan catabolism in metabolic syndrome
  publication-title: Metab Synd Relat Disord
– volume: 388
  start-page: 2796
  year: 2016
  end-page: 810
  article-title: Bladder cancer
  publication-title: Lancet
– volume: 56
  start-page: 83
  year: 2018
  end-page: 8
  article-title: Mass spectrometric measurement of urinary kynurenine‐to‐tryptophan ratio in children with and without urinary tract infection
  publication-title: Clin Biochem
– volume: 10
  start-page: 6977
  year: 2004
  end-page: 84
  article-title: Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony‐stimulating factor therapy using the prostate‐specific antigen gene as a reporter
  publication-title: Clin Cancer Res
– volume: 37
  start-page: 358
  issue: 7_suppl
  year: 2019
  article-title: BMS‐986205, an indoleamine 2, 3‐dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (nivo): updated safety across all tumor cohorts and efficacy in advanced bladder cancer (advBC)
  publication-title: J Clin Oncol
– volume: 32
  start-page: 1093
  year: 2014
  end-page: 104
  article-title: The health economics of bladder cancer: an updated review of the published literature
  publication-title: Pharmacoeconomics
– volume: 9
  start-page: 31
  year: 2016
  end-page: 49
  article-title: Assessment of the human kynurenine pathway: comparisons and clinical implications of ethnic and gender differences in plasma tryptophan, kynurenine metabolites, and enzyme expressions at baseline and after acute tryptophan loading and depletion
  publication-title: Int J Tryptophan Res
– volume: 10
  start-page: 117864691769460
  year: 2017
  article-title: Tryptophan metabolism in patients with chronic kidney disease secondary to type 2 diabetes: Relationship to inflammatory markers
  publication-title: Int J Tryptophan Res
– volume: 19
  start-page: 666
  year: 2001
  end-page: 75
  article-title: Radical cystectomy in the treatment of invasive bladder cancer: long‐term results in 1,054 patients
  publication-title: J Clin Oncol
– volume: 37
  start-page: TPS493
  year: 2019
  article-title: A phase II, randomized study of nivolumab (nivo) or nivo plus BMS‐986205 with or without intravesical Bacillus Calmette‐Guerin (BCG) in BCG‐unresponsive, high‐risk, non‐muscle invasive bladder cancer (NMIBC): CheckMate 9UT
  publication-title: J Clin Oncol
– volume: 56
  start-page: 430
  year: 2009
  end-page: 42
  article-title: Recurrence and Progression of disease in non‐muscle‐invasive bladder cancer: from epidemiology to treatment strategy
  publication-title: Eur Urol
– volume: 163
  start-page: 922
  year: 2015
  article-title: Urinary biomarkers for diagnosis of bladder cancer
  publication-title: Ann Intern Med
– volume: 187
  start-page: 1617
  year: 2011
  end-page: 25
  article-title: IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells
  publication-title: J Immunol
– volume: 104
  start-page: 41
  year: 2009
  end-page: 7
  article-title: Non‐muscle‐invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost‐effective alternative?
  publication-title: BJU Int
– volume: 196
  start-page: 1021
  year: 2016
  end-page: 9
  article-title: Diagnosis and treatment of non‐muscle invasive bladder cancer: AUA/SUO guideline
  publication-title: J Urol
– volume: 77
  start-page: 6795
  year: 2017
  end-page: 811
  article-title: Discovery of IDO1 inhibitors: from bench to bedside
  publication-title: Cancer Res
– volume: 102
  start-page: 1242
  year: 2008
  end-page: 6
  article-title: Quality control in transurethral resection of bladder tumours
  publication-title: BJU Int
– volume: 109
  start-page: 2497
  year: 2012
  end-page: 502
  article-title: Reversal of tumoral immune resistance by inhibition of tryptophan 2,3‐dioxygenase
  publication-title: Proc Natl Acad Sci USA
– volume: 25
  start-page: 1462
  year: 2019
  end-page: 71
  article-title: Reimagining IDO pathway inhibition in cancer immunotherapy via downstream focus on the tryptophan–kynurenine–aryl hydrocarbon axis
  publication-title: Clin Cancer Res
– volume: 2017
  start-page: 755
  year: 2015
  end-page: 65
  article-title: Bladder cancer: diagnosis and management of bladder cancer: © NICE (2015) Bladder cancer: diagnosis and management of bladder cancer
  publication-title: BJU Int
– volume: 33
  start-page: 1071
  year: 1973
  end-page: 7
  article-title: Studies on tryptophan metabolism in patients with bladder cancer
  publication-title: Cancer Res
– volume: 12
  start-page: 485
  year: 2019
  end-page: 92
  article-title: Overexpression of indoleamine 2,3‐dioxygenase 1 promotes epithelial‐mesenchymal transition by activation of the IL‐6/STAT3/PD‐L1 pathway in bladder cancer
  publication-title: Transl Oncol
– volume: 478
  start-page: 197
  year: 2011
  end-page: 203
  article-title: An endogenous tumour‐promoting ligand of the human aryl hydrocarbon receptor
  publication-title: Nature
– volume: 60
  start-page: 277
  year: 2010
  end-page: 300
  article-title: Cancer statistics, 2010
  publication-title: CA Cancer J Clin
– volume: 347
  start-page: 1260419
  year: 2015
  article-title: Tissue‐based map of the human proteome
  publication-title: Science
– volume: 1054
  start-page: 36
  year: 2017
  end-page: 43
  article-title: Simultaneous determination of tryptophan and 8 metabolites in human plasma by liquid chromatography/tandem mass spectrometry
  publication-title: J Chromatogr B Anal Technol Biomed Life Sci
– volume: 63
  start-page: 4
  year: 2013
  end-page: 15
  article-title: ICUD‐EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers
  publication-title: Eur Urol
– volume: 119
  start-page: 371
  year: 2017
  end-page: 80
  article-title: Guideline of guidelines: non‐muscle‐invasive bladder cancer
  publication-title: BJU Int
– volume: 9
  start-page: 2988
  year: 2010
  end-page: 95
  article-title: Noninvasive urinary metabonomic diagnosis of human bladder cancer
  publication-title: J Proteome Res
– ident: e_1_2_7_25_1
  doi: 10.1158/0008-5472.CAN-17-2285
– ident: e_1_2_7_8_1
  doi: 10.1007/s40273-014-0194-2
– ident: e_1_2_7_26_1
  doi: 10.1200/JCO.2019.37.7_suppl.358
– volume: 8
  start-page: 1768
  year: 2015
  ident: e_1_2_7_18_1
  article-title: Expression and function analysis of indoleamine 2 and 3‐dioxygenase in bladder urothelial carcinoma
  publication-title: Int J Clin Exp Pathol
  contributor:
    fullname: Yang C
– ident: e_1_2_7_27_1
  doi: 10.1200/JCO.2019.37.7_suppl.TPS493
– ident: e_1_2_7_9_1
  doi: 10.1111/j.1464-410X.2008.08323.x
– ident: e_1_2_7_13_1
  doi: 10.7326/M15-0997
– ident: e_1_2_7_17_1
  doi: 10.1038/nature10491
– ident: e_1_2_7_10_1
  doi: 10.1111/bju.13760
– ident: e_1_2_7_21_1
  doi: 10.1016/j.jchromb.2017.04.010
– ident: e_1_2_7_28_1
  doi: 10.1158/1078-0432.CCR-18-2882
– ident: e_1_2_7_19_1
  doi: 10.1016/j.tranon.2018.11.012
– ident: e_1_2_7_3_1
  doi: 10.3322/caac.20073
– ident: e_1_2_7_20_1
  doi: 10.1158/1078-0432.CCR-04-0605
– ident: e_1_2_7_5_1
  doi: 10.1111/j.1464-410X.2008.07966.x
– ident: e_1_2_7_2_1
  doi: 10.1016/S0140-6736(16)30512-8
– ident: e_1_2_7_22_1
  doi: 10.1126/science.1260419
– ident: e_1_2_7_4_1
  doi: 10.1016/j.eururo.2009.06.028
– ident: e_1_2_7_6_1
  doi: 10.1200/JCO.2001.19.3.666
– ident: e_1_2_7_23_1
  doi: 10.1073/pnas.1113873109
– ident: e_1_2_7_7_1
  doi: 10.1016/j.juro.2016.06.049
– volume: 2017
  start-page: 755
  year: 2015
  ident: e_1_2_7_12_1
  article-title: Bladder cancer: diagnosis and management of bladder cancer: © NICE (2015) Bladder cancer: diagnosis and management of bladder cancer
  publication-title: BJU Int
  contributor:
    fullname: (NICE) NI of H and CE
– ident: e_1_2_7_11_1
  doi: 10.1016/j.eururo.2012.09.057
– volume: 33
  start-page: 1071
  year: 1973
  ident: e_1_2_7_15_1
  article-title: Studies on tryptophan metabolism in patients with bladder cancer
  publication-title: Cancer Res
  contributor:
    fullname: Gailani S
– ident: e_1_2_7_14_1
  doi: 10.1021/pr901173v
– ident: e_1_2_7_31_1
  doi: 10.1016/j.clinbiochem.2018.04.014
– ident: e_1_2_7_29_1
  doi: 10.4137/IJTR.S38189
– ident: e_1_2_7_24_1
  doi: 10.4049/jimmunol.1000815
– ident: e_1_2_7_16_1
  doi: 10.1177/1178646917694600
– ident: e_1_2_7_30_1
  doi: 10.1089/met.2017.0097
SSID ssj0014665
Score 2.502656
Snippet Objectives To investigate plasma and urinary kynurenine (KYN)–tryptophan (TRP) ratios in bladder cancer, expression of indoleamine 2,3‐dioxygenase 1 (IDO1) in...
To investigate plasma and urinary kynurenine (KYN)-tryptophan (TRP) ratios in bladder cancer, expression of indoleamine 2,3-dioxygenase 1 (IDO1) in relation to...
ObjectivesTo investigate plasma and urinary kynurenine (KYN)–tryptophan (TRP) ratios in bladder cancer, expression of indoleamine 2,3‐dioxygenase 1 (IDO1) in...
OBJECTIVESTo investigate plasma and urinary kynurenine (KYN)-tryptophan (TRP) ratios in bladder cancer, expression of indoleamine 2,3-dioxygenase 1 (IDO1) in...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 445
SubjectTerms Animal models
biomarker
Biomarkers
Bladder cancer
BladderCancer
blcsm
Cancer
Creatinine
Dioxygenase
kynurenine
Prostate
surveillance
Tryptophan
Tumors
uroonc
utuc
Title Tryptophan–kynurenine ratio as a biomarker of bladder cancer
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbju.15205
https://www.ncbi.nlm.nih.gov/pubmed/32794357
https://www.proquest.com/docview/2511089837
https://search.proquest.com/docview/2434481841
Volume 127
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB5CAqGXtkn_3G6CUnroxcG2pPWKQGG3ybIEkkPIQg4FI9nSoSne4F0ftqe-Q98wT5IZ-YcmJRByskESsjUz0jfS6BuAL0O0mcQKFSZFykOhchlqI1WoRSSsjRwuKbTfcXY-nM3F6ZW82oCj7i5Mww_Rb7iRZfj5mgxcm-U_Rm5-1pS8x_OXxjylcL7ji546CicAn0YSnwJ9JDVsWYUoiqdveX8t-g9g3serfsGZvoIf3ac2cSbXh_XKHOa_H7A4PvNfXsPLFoiycaM5O7Bhy13YPmuP2t_At8tqfUOsA7q8_fP3ek0XikssYV5lmF4yzejuPoX3VGzhmPlFk1jFctKj6i3MpyeX32dhm2whzLnkMhxpI1JH6ael1YgLDQKz2CU2LZx1EmVWKIR-RnKRa5moXBORvlbWCONi6xL-DjbLRWk_ACsQsEdS28KpkZCU3yeKDXcmyVNKau0C-NwNe3bTcGpknS-CI5H5kQhg0Akka81qmZE_FI0UOtUBHPTFaBB0yqFLu6ixjuDocqLjGgfwvhFk3wtPiA9PYuuvXhyPd59NTuf-5ePTq36CFwlFvPi4ngFsrqra7iFkWZl92BpPjifTfa-jdyV250w
link.rule.ids 314,780,784,1375,27924,27925,46294,46718
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSyQxEC5EQffic1fHZ5Q97KWlH8nMBETwyfgYD8sMeJEm6U4OjvRIO3PQk__Bf-gvsSr9QFcWxFM3JCHdqarkq6TyFcDvJtpMaLj0wrQVeVwmwlNaSE9xnxvjW1xSaL-je9Xs9Pn5tbiegL3qLkzBD1FvuJFluPmaDJw2pN9Zub4dU_YeIjCdQnMPKKDr-G9NHoVTgEskiU-OXpJslrxCFMdTN_24Gn2CmB8Rq1tyTufgpvrYItJksDse6d3k6R8ex-_-zTzMlliUHRTKswATJluE6W552r4E-7388Z6IB1T2-vwyeKQ7xRmWMKc1TD0wxej6PkX45Gxomb6jeSxnCalS_hP6pye9o45X5lvwkkhEwmsrzVuWMlALoxAaasRmgQ1NK7XGChRbKhH9aRHxRIlQJoq49JU0mmsbGBtGv2AyG2ZmBViKmN0XyqRWtrmgFD9-oCOrw6RFea1tA3aqcY_vC1qNuHJHcCRiNxINWK8kEpeW9RCTS-S3JfrVDdiui9Em6KBDZWY4xjo8Qq8TfdegAcuFJOteopAo8QS2_uPk8f_u48PzvntZ_XrVLZjp9LqX8eXZ1cUa_AgpAMaF-azD5Cgfmw1EMCO96RT1DWLu6fs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NahsxEB5CCqGXtkmb1onTqCGHXDastZJtESi0TYzr_FCKDT4EFmlXOtRlbdb2wT31HfKGeZLMaH9oEgKhp12QhHY1M9I30ugbgMM22gy3QgU87USBUIkMtJEq0CIU1oYOlxTa77i8avdHYjCW4zU4qe7CFPwQ9YYbWYafr8nAZ6n7x8jNryUl7yH-0heizRUR55_-rLmjcAbweSTxKdBJUu2SVojCeOqm9xejRwjzPmD1K07vNVxX31oEmkyOlwtznPx5QOP4nz_zBl6VSJR9KVRnE9ZstgUbl-VZ-1v4PMxXM6Id0Nnt35vJim4UZ1jCvM4wPWea0eV9iu_J2dQx85tmsZwlpEj5Oxj1zobf-kGZbSFIIhnJoKuN6DjKPy2tRmBoEJm1HLed1FknUWipQuxnZCQSLblKNDHpa2WNMK5lHY-2YT2bZvYDsBQReyi1TZ3qCkkJfsKWiZzhSYeyWrsGHFTDHs8KUo24ckZwJGI_Eg1oVgKJS7uax-QQhV2FXnUDPtXFaBF0zKEzO11iHRGhz4mea6sB7wtB1r1EnAjxJLY-8uJ4uvv462DkX3aeX3UfNn6c9uKL71fnu_CSU_SLj_FpwvoiX9o9hC8L89Gr6R26Meiq
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tryptophan-kynurenine+ratio+as+a+biomarker+of+bladder+cancer&rft.jtitle=BJU+international&rft.au=Lee%2C+Sze+Han&rft.au=Mahendran%2C+Ratha&rft.au=Tham%2C+Sin+Mun&rft.au=Thamboo%2C+Thomas+Paulraj&rft.date=2021-04-01&rft.eissn=1464-410X&rft.volume=127&rft.issue=4&rft.spage=445&rft.epage=453&rft_id=info:doi/10.1111%2Fbju.15205&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon